Back
Regeneron Pharmaceuticals Stock Predictions

Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
REGN
Regeneron Pharmaceuticals
Last Price:
$696.47
Seasonality Move:
1.02%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Space Move Could Send This Pre-IPO Stock Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Regeneron Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 21.8% based on the past 33 years of stock performance.
-
Regeneron Pharmaceuticals has risen higher in 16 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.48%
-
Is Regeneron Pharmaceuticals Stock Undervalued?The current Regeneron Pharmaceuticals [REGN] share price is $685.66. The Score for REGN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 21.8% based on the past 33 years of stock performance.
Regeneron Pharmaceuticals Stock Rating
Sell
40
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals overpriced?
-
Regeneron Pharmaceuticals has risen higher in 16 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.48%
Regeneron Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
1,211.20
52-Week Low:
642.00
Prediction Charts
Market Cap:
75B
Price in USD:
685.66
Volume:
638K
Beta:
0.95
Technical Analysis
SMA50:
708.32
SMA100:
801.19
SMA200:
935.26
52-Wk Change:
-27.68%
Stock Predictions
-
Is Regeneron Pharmaceuticals stock public?Yes, Regeneron Pharmaceuticals is a publicly traded company.
-
What is the Regeneron Pharmaceuticals stock quote today?The Regeneron Pharmaceuticals stock price is 685.66 USD today.
-
How to buy Regeneron Pharmaceuticals stock online?You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-31 | 677.29 | 672.98 | 688.00 | 671.96 |
Feb-3 | 668.80 | 666.85 | 673.65 | 663.43 |
Feb-4 | 650.00 | 697.05 | 709.98 | 642.00 |
Feb-5 | 708.80 | 716.72 | 729.25 | 700.01 |
Feb-6 | 713.42 | 722.07 | 734.27 | 713.42 |
Feb-7 | 726.46 | 710.00 | 731.42 | 709.55 |
Feb-10 | 714.45 | 690.36 | 719.78 | 688.92 |
Feb-11 | 680.63 | 665.46 | 680.79 | 664.19 |
Feb-12 | 659.96 | 663.86 | 670.98 | 655.85 |
Feb-13 | 665.46 | 674.27 | 677.69 | 661.94 |
Feb-14 | 678.20 | 673.60 | 684.00 | 671.55 |
Feb-18 | 679.64 | 680.00 | 689.95 | 674.88 |
Feb-19 | 675.29 | 685.66 | 688.67 | 675.29 |
Feb-20 | 688.05 | 696.02 | 703.14 | 685.45 |
Regeneron Pharmaceuticals Earnings
Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals Forecast Revenue Growth
Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.85 per share, an increase next quarter of $0.43 per share, a decrease this year of $1.83 per share, and an increase next year of $3.98 per share.
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.